FDA website to post names of drug makers blocking development of cheaper generics image

Marketplace, May 17, 2018
Dan Gorenstein, quoting Rachel Sachs (Academic Fellow Alumna)


Read the Full Article

From the article:

The FDA plans to unveil a website today naming pharmaceutical companies that have blocked the development of generic drugs by failing to provide samples to competitors. This public posting is part of FDA Commissioner Scott Gottlieb's larger crackdown to, as he says, “end the shenanigans” by brand name drug companies.

Listen to the full article here!

pharmaceuticals rachel sachs regulation